ID   NFS-1
AC   CVCL_1Y69
DR   Cosmic; 1132065
DR   Cosmic; 1801807
DR   Wikidata; Q54930435
RX   PubMed=18650488;
RX   PubMed=23437333;
CC   Misspelling: NSF-1; Cosmic=1801807.
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
RX   PubMed=18650488; DOI=10.1215/15228517-2008-053; PMCID=PMC2719009;
RA   Holtkamp, Nikola
RA   Malzer, Elke
RA   Zietsch, Jan
RA   Okuducu, Ali Fuat
RA   Mucha, Jana
RA   Mawrin, Christian
RA   Mautner, Victor-Felix
RA   Schildhaus, Hans-Ulrich
RA   von Deimling, Andreas
RT   "EGFR and erbB2 in malignant peripheral nerve sheath tumors and
RT   implications for targeted therapy.";
RL   Neuro-oncol. 10:946-957(2008).
//
RX   PubMed=23437333; DOI=10.1371/journal.pone.0057152; PMCID=PMC3578816;
RA   Reuss, David E.
RA   Mucha, Jana
RA   Hagenlocher, Christian
RA   Ehemann, Volker
RA   Kluwe, Lan
RA   Mautner, Victor-Felix
RA   von Deimling, Andreas
RT   "Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL
RT   is augmented by loss of NF1 through modulation of MYC/MAD and is
RT   potentiated by curcumin through induction of ROS.";
RL   PLoS ONE 8:e57152.1-e57152.10(2013).
//